Jan 26, 2018 - AbbVie's (ABBV) Q4 earnings top estimates with revenues marginally beating the same. Sales of the company's lead marketed drug, Humira, also rise year over year.
Jan 24, 2018 - Sanofi's leap into an undeniably big market could face challenges as treatment evolves.
Jan 23, 2018 - Does Celgene's (CELG) decision to acquire Juno signal the revival of biotech M&A activity after a slow 2017?
Jan 21, 2018 - Both big pharma stocks have growth drivers. But both also come with baggage.
Jan 19, 2018 - The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis
Jan 18, 2018 - We present four large cap drug companies, which are expected to repeat their last year's industry beating performance in 2018.
Jan 17, 2018 - The outlook is complicated for this big pharma stock.
Jan 17, 2018 - Regulatory approvals of some key pipeline candidates along with the strong performance of products like Victoza have contributed to a rally in Novo Nordisk's (NVO) shares.
Jan 16, 2018 - Teva Pharmaceutical (TEVA) receives approval from the FDA for label expansion of its leukemia drug, Trisenox, in first-line setting.
Jan 15, 2018 - Global markets endured a volatile week, guided by opposing factors.